GER Equity Snapshot

VX1 Weekly Equity Report

Vertex Pharmaceuticals Incorporated

Interactive chart JSON snapshot
Latest Close 382.3 EUR 12 Jun 2026
1W Return -1.8% latest completed week
4W Return 0.7% short-term follow-through
12W Return -3.3% quarterly tape
Trend Breadth 26.9% 14 of 52 weeks active
Volume Ratio 0.5x vs 13-week average
Company Brief

What the company does

Vertex Pharmaceuticals Incorporated operates as a biotechnology company in the United States, Europe, and internationally. The company offers transformative medicines for people with serious diseases with a focus on specialty markets, such as cystic fibrosis (CF), sickle cell disease (SCD), transfusion dependent beta thalassemia (TDT), and acute pain. It markets TRIKAFTA/KAFTRIO for people with CF with at least one F508del mutation for 2 years of age and older; ALYFTREK for the treatment for people with CF 6 years of age and older; SYMDEKO/SYMKEVI for treatment of patients with CF 6 years of age and older; …

Snapshot

What the weekly tape is saying

VX1 closed the latest completed week at 382.3 EUR. The 4-week return is 0.7% and the 12-week return is -3.3%. Trend Signal is inactive, Market Dynamics is -0.49. Setup signature: Risk-first tape with a 39/100 composite read.

Trend Signal Inactive
Market Dynamics No fresh buy
Price vs Trend -1.4%
Volume 0.5x
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 15 Persistence of active Trend Signal over the last year and current streak.
Momentum 49 Blend of 4-week and 12-week follow-through.
Dynamics 45 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 37 Relative leadership and short-term RS change.
Volume 23 Participation compared with the 13-week volume baseline.
Risk Control 66 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
387.6 EUR
Vs Trend Line
-1.4%
Fair Value
389.3 EUR
Vs Fair Value
-1.8%
52W High
433.2 EUR
52W Low
312.6 EUR
Drawdown
-11.8%
Range Position
57.8%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W -1.8%
4W 0.7%
12W -3.3%
26W -0.7%
52W -3.5%

Trend read

Active Streak
0 weeks
52W Active Weeks
14
52W Active Breadth
26.9%
Sector Scope
DE Healthcare
Sector Rank
46 of 80
Sector Percentile
43.0%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
-0.49
4W MD Change
52.3%
Relative Strength
-0.51
4W RS Change
-143.4%
Expectation
Positive
Probability
64.17%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
157
13W Average
288
52W Average
1.2K
Vs 13W
0.5x
Vs 52W
0.1x
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
2.1%
52W Volatility
4.0%
Upside Weeks
26
Downside Weeks
26
Downside Breadth
50.0%
Avg Gain / Loss
2.7% / -2.6%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
GER
Country
DE
Sector
Healthcare
Industry
Biotechnology
Currency
EUR
Market Cap
97.3B

Opportunity signals

  • No strong opportunity cluster is confirmed yet; monitor trend and Market Dynamics.

Risk signals

  • Trend Signal is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Market Dynamics is negative, which weakens the current setup.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 382.3 EUR -1.8% 387.6 EUR 389.3 EUR -0.49 -0.51 157 Off
5 Jun 2026 389.4 EUR 1.5% 387.6 EUR 388.9 EUR -0.60 0.66 168 Off
29 May 2026 383.5 EUR 1.9% 386.6 EUR 388.4 EUR -0.66 -2.28 672 Off
22 May 2026 376.2 EUR -0.9% 386.0 EUR 387.9 EUR -0.93 -3.41 319 Off
15 May 2026 379.8 EUR 4.4% 385.7 EUR 387.4 EUR -1.02 1.18 488 Off
8 May 2026 363.8 EUR -0.6% 384.8 EUR 387.0 EUR -1.14 -4.68 591 Off
1 May 2026 366.0 EUR -0.4% 384.4 EUR 386.8 EUR -1.22 -4.08 53 Off
24 Apr 2026 367.5 EUR -1.0% 383.8 EUR 386.4 EUR -1.14 -3.53 112 Off
17 Apr 2026 371.3 EUR -0.5% 382.5 EUR 386.1 EUR -1.01 -5.26 361 Off
10 Apr 2026 373.2 EUR -2.5% 381.1 EUR 385.6 EUR -0.82 -1.79 173 On
3 Apr 2026 383.0 EUR 0.0% 379.9 EUR 385.1 EUR -0.43 2.92 161 On
27 Mar 2026 382.9 EUR -3.1% 378.4 EUR 384.5 EUR -0.13 6.29 296 On
20 Mar 2026 395.2 EUR -3.9% 376.8 EUR 383.9 EUR 0.27 8.89 199 On
13 Mar 2026 411.2 EUR 5.2% 375.0 EUR 383.2 EUR 0.55 7.80 418 On